AGP Executive Report
Last update: 8 hours agoCBD & Cancer Fundraising: Deni Angels of Chaos hit a $30,000 goal for the Cancer Council after a CBD pop-up and community sausage sizzles, with more rally fundraising planned across remote parts of Australia. FDA & Pain Treatment: The FDA granted Breakthrough Therapy Designation to VER-01, a cannabis-derived full-spectrum drug for chronic low back pain, citing Phase 3 results showing meaningful pain reduction and better GI tolerability than opioids. Policy Clash (Kentucky): Kentucky lawmakers are pushing the state AG to prosecute cannabis licensees tied to Gov. Beshear’s expansion of qualifying medical conditions, including serious diseases like ALS, HIV/AIDS, and fibromyalgia. Hemp Retail Rules (Pennsylvania): Pennsylvania’s Senate Bill 49 failed to advance, leaving regulation of intoxicating hemp THC products largely unchanged despite calls for tighter limits and a Cannabis Control Board. Youth Use & Risks: New reporting highlights rising cannabis use among teens and the potential for dependence and mental health impacts, urging balanced conversations about benefits and harms. Medical Cannabis Access (Rescheduling): Coverage continues around federal medical marijuana rescheduling and what it could mean for research and patient access. Health & Safety (Boating): A drowning report in Saskatchewan notes alcohol and marijuana can be factors, with life jackets stressed as a key prevention step.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![Gumitide Gummies [URGENT REPORT 2026] Gumitide Shocking Boom Why Everyone Is Talking About This Weight Loss Gummies](https://ml.globenewswire.com/media/fa2dec49-162d-49d3-b9be-ad7d02b76f1f/medium/gumitide.png)
